Arcellx Ownership | Who Owns Arcellx?
Arcellx Ownership Summary
Arcellx is owned by 91.95% institutional investors, 12.62% insiders. Fmr is the largest institutional shareholder, holding 12.30% of ACLX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.51% of its assets in Arcellx shares.
ACLX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcellx | 91.95% | 12.62% | -4.57% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 6.49M | 12.30% | $358.04M |
| Perceptive advisors | 3.89M | 7.37% | $214.67M |
| Paradigm biocapital advisors lp | 3.85M | 7.29% | $212.38M |
| Nea management company | 3.75M | 7.10% | $206.70M |
| Blackrock | 3.52M | 6.67% | $194.07M |
| Sr one capital management, lp | 2.35M | 4.45% | $129.51M |
| Vanguard group | 2.30M | 4.35% | $126.73M |
| Janus henderson group | 1.90M | 3.61% | $104.98M |
| State street | 1.76M | 3.33% | $96.90M |
| Price t rowe associates inc /md/ | 1.63M | 3.09% | $90.00M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sr one capital management, lp | 2.35M | 40.55% | $129.51M |
| Nea management company | 3.75M | 15.55% | $206.70M |
| Paradigm biocapital advisors lp | 3.85M | 8.13% | $212.38M |
| Samsara biocapital | 453.64K | 5.24% | $25.04M |
| Great point partners | 492.00K | 5.20% | $27.15M |
| Perceptive advisors | 3.89M | 5.10% | $214.67M |
| Cormorant asset management, lp | 1.52M | 4.86% | $84.16M |
| Cutter capital management, lp | 187.00K | 3.12% | $10.32M |
| Suvretta capital management | 1.52M | 3.07% | $83.68M |
| Affinity asset advisors | 460.00K | 2.93% | $25.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 1.60M | 1.17% | 1.60M |
| Fmr | 6.49M | 0.02% | 1.09M |
| Vestal point capital, lp | 675.00K | 2.78% | 575.00K |
| Blackrock | 3.52M | 0.00% | 450.30K |
| Janus henderson group | 1.90M | 0.06% | 380.31K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lord, abbett | 873.84K | 0.16% | -324.27K |
| Jpmorgan chase | 261.36K | 0.00% | -290.39K |
| Cormorant asset management, lp | 1.52M | 4.86% | -255.00K |
| Federated hermes | 5.73K | 0.00% | -225.93K |
| Voya investment management | 215.24K | 0.01% | -165.08K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 1.60M | 1.17% | 1.60M | $88.53M |
| Jacobs levy equity management | 47.82K | 0.01% | 47.82K | $2.64M |
| Corebridge financial | 23.19K | 0.01% | 23.19K | $1.28M |
| Mirae asset global etfs | 22.75K | 0.00% | 22.75K | $1.25M |
| Handelsbanken fonder ab | 10.30K | 0.00% | 10.30K | $568.00K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -19.00 |
| Clear street markets | -42.00 |
| Lindbrook capital | -85.00 |
| Entrypoint capital | -142.00 |
| Pacer advisors | -488.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 201 | 19.64% | 49,489,251 | -1.47% | 91 | 1.04% | 108 | 6.93% | 61 | 22.00% |
| Jun 30, 2024 | 165 | -10.33% | 50,204,759 | 6.85% | 95 | 1.18% | 99 | -8.33% | 49 | -15.52% |
| Mar 31, 2024 | 184 | 12.20% | 46,986,953 | 0.53% | 89 | 0.97% | 108 | 11.34% | 58 | 20.83% |
| Dec 31, 2023 | 164 | 19.71% | 46,737,584 | -1.77% | 96 | 0.99% | 97 | 29.33% | 48 | 26.32% |
| Sep 30, 2023 | 137 | -2.14% | 47,577,709 | -1.28% | 98 | 0.93% | 75 | -25.74% | 38 | 22.58% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.36M | 2.51% | 1.55K |
| iShares Russell 2000 ETF | 1.16M | 2.15% | -4.45K |
| Fidelity Select Biotechnology | 1.04M | 1.93% | -25.00K |
| T. Rowe Price Health Sciences | 884.09K | 1.64% | -2.34K |
| SPDR® S&P Biotech ETF | 809.12K | 1.50% | -9.47K |
| Fidelity Growth Compy Commingled Pl S | 775.80K | 1.43% | 1.14K |
| Fidelity Growth Compy Commingled Pl O | 764.28K | 1.42% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 586.65K | 1.08% | 11.71K |
| Fidelity Select Health Care | 580.00K | 1.07% | 120.00K |
| Fidelity Small Cap Growth | 577.63K | 1.07% | 36.66K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 14, 2025 | Patel Kavita | - | Sell | $20.20K |
| Jan 14, 2025 | Patel Kavita | - | Sell | $26.65K |
| Jan 14, 2025 | Patel Kavita | - | Sell | $51.96K |
| Jan 07, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | $319.48K |
| Jan 08, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | $261.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 23 |
| 2024 Q3 | - | 24 |
| 2024 Q2 | - | 16 |
| 2024 Q1 | - | 22 |
| 2023 Q4 | - | 4 |
ACLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools